BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 28889184)

  • 1. Cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and its correlation with sonographic knee cartilage thickness and disease activity.
    Sakthiswary R; Rajalingam S; Hussein H; Sridharan R; Asrul AW
    Clin Rheumatol; 2017 Dec; 36(12):2683-2688. PubMed ID: 28889184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and knee osteoarthritis.
    Wisłowska M; Jabłońska B
    Clin Rheumatol; 2005 Jun; 24(3):278-84. PubMed ID: 15940561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cartilage oligomeric matrix protein (COMP): the role of a non-collagen cartilage matrix protein as a marker of disease activity and joint destruction in patients with rheumatoid arthritis and osteoarthritis].
    Marti C; Neidhart M; Gerber T; Hauser N; Michel BA; Häuselmann HJ
    Z Rheumatol; 1999 Apr; 58(2):79-87. PubMed ID: 10408068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and synovial cartilage oligomeric matrix protein levels in early and established rheumatoid arthritis.
    El Defrawy AO; Gheita TA; Raslan HM; El Ansary MM; El Awar AH
    Z Rheumatol; 2016 Nov; 75(9):917-923. PubMed ID: 26683321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cross sectional study of bone and cartilage biomarkers: correlation with structural damage in rheumatoid arthritis.
    Ben Achour W; Bouaziz M; Mechri M; Zouari B; Bahlous A; Abdelmoula L; Laadhar L; Sellami M; Sahli H; Cheour E
    Libyan J Med; 2018 Dec; 13(1):1512330. PubMed ID: 30160204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between suprapatellar pouch effusion-synovitis, serum cartilage oligomeric matrix protein, high sensitivity C-reaction protein, knee symptom, and joint structural changes in patients with knee osteoarthritis.
    Yang X; Ruan G; Xu J; Zheng S; Wang K; Ding C
    Clin Rheumatol; 2020 May; 39(5):1663-1670. PubMed ID: 31897961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of sonographic severity with biochemical markers of synovium and cartilage in knee osteoarthritis patients.
    Jung YO; Do JH; Kang HJ; Yoo SA; Yoon CH; Kim HA; Cho CS; Kim WU
    Clin Exp Rheumatol; 2006; 24(3):253-9. PubMed ID: 16870091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early diagnostic and prognostic values of anti-cyclic citrullinated peptide antibody and cartilage oligomeric matrix protein in rheumatoid arthritis.
    Algergawy SA; Abd El-Sabour M; Osman AS; Emam SM; Elham N
    Egypt J Immunol; 2013; 20(2):11-20. PubMed ID: 24617043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokines, metalloproteinases, their inhibitors and cartilage oligomeric matrix protein: relationship to radiological progression and inflammation in early rheumatoid arthritis. A prospective 5-year study.
    Roux-Lombard P; Eberhardt K; Saxne T; Dayer JM; Wollheim FA
    Rheumatology (Oxford); 2001 May; 40(5):544-51. PubMed ID: 11371663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COMP-C3b complexes in rheumatoid arthritis with severe extraarticular manifestations.
    Happonen KE; Saxne T; Jacobsson L; Sturfelt G; Rönnelid J; Mollnes TE; Heinegård D; Turesson C; Blom AM
    J Rheumatol; 2013 Dec; 40(12):2001-5. PubMed ID: 24187101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation.
    Neidhart M; Hauser N; Paulsson M; DiCesare PE; Michel BA; Häuselmann HJ
    Br J Rheumatol; 1997 Nov; 36(11):1151-60. PubMed ID: 9402858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrement of serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis (RA) patients achieving remission after 6 months of etanercept treatment: comparison with CRP, IgM-RF, MMP-3 and anti-CCP Ab.
    Kawashiri SY; Kawakami A; Ueki Y; Imazato T; Iwamoto N; Fujikawa K; Aramaki T; Tamai M; Nakamura H; Origuchi T; Ida H; Eguchi K
    Joint Bone Spine; 2010 Oct; 77(5):418-20. PubMed ID: 20864374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Serum cartilage oligomeric matrix protein (COMP) in the diagnosis of rheumatoid arthritis (RA): A case-control study.
    Liu F; Wang X; Zhang X; Ren C; Xin J
    J Int Med Res; 2016 Aug; 44(4):940-9. PubMed ID: 27217240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of cartilage oligomeric matrix protein. A predicting factor and a valuable parameter for disease management in rheumatoid arthritis.
    Skoumal M; Kolarz G; Klingler A
    Scand J Rheumatol; 2003; 32(3):156-61. PubMed ID: 12892252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cartilage oligomeric protein, matrix metalloproteinase-3, and Coll2-1 as serum biomarkers in knee osteoarthritis: a cross-sectional study.
    Georgiev T; Ivanova M; Kopchev A; Velikova T; Miloshov A; Kurteva E; Yuzeir K; Penkov M; Kabakchieva P; Rashkov R; Stoilov R
    Rheumatol Int; 2018 May; 38(5):821-830. PubMed ID: 29164307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum calprotectin (S100A8/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis.
    Hurnakova J; Zavada J; Hanova P; Hulejova H; Klein M; Mann H; Sleglova O; Olejarova M; Forejtova S; Ruzickova O; Komarc M; Vencovsky J; Pavelka K; Senolt L
    Arthritis Res Ther; 2015 Sep; 17(1):252. PubMed ID: 26373925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cartilage oligomeric matrix protein in serum in systemic lupus erythematosus and knee osteoarthritis. Preliminary communication.
    Wisłowska M; Jabłońska B
    Rheumatol Int; 2005 Jun; 25(5):373-8. PubMed ID: 15739097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The degree of cartilage degradation assessed by serum biomarker levels changes after arthroscopic knee synovectomy in rheumatoid arthritis patients.
    Lipina M; Makarov M; Makarov S; Novikov A
    Int Orthop; 2017 Nov; 41(11):2259-2264. PubMed ID: 28889180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can tocilizumab decrease cartilage oligomeric matrix protein levels and disease activity in patients with long-standing rheumatoid arthritis?
    Benucci M; Meacci F; Manfredi M; Gobbi FL; Infantino M; Ricci C; Sarzi-Puttini P; Atzeni F
    Curr Rheumatol Rev; 2014; 10(2):131-5. PubMed ID: 25599685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arthrosonography and biomarkers in the evaluation of destructive knee cartilage osteoarthrosis].
    Zivanović S; Petrović-Rackov L; Zivanović A
    Srp Arh Celok Lek; 2009; 137(11-12):653-8. PubMed ID: 20069924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.